NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Federal Leaders Revamp Tech Workforce, Policy
Despite the rise in interest of emerging technology, federal leaders see data, policy and the workforce as a best vehicle for change.
4m read -
Looking Back at the First Trump Administration's Tech Priorities
In his first term, Donald Trump supported cybersecurity, space policy and artificial intelligence development.
4m read -
Labor CAIO Outlines Responsible and Ethical AI Priorities, Use Cases
Department of Labor Chief AI Officer Mangala Kuppa outlined how her role is shaping the agency’s artificial intelligence strategy.
20m watch -
Elevating Cybersecurity in the Intelligence Community
The Intelligence Community is developing strategies to protect data and strengthen resiliency against emerging cyber threats.
30m watch
